Cite
MLA Citation
S Rahmany et al.. “PTU-073 In Patients with IBD Switching from Originator Infliximab (Remicade) to Biosimilar Infliximab (CT-P13) Is Safe and Effective.” Gut, vol. 65, n.d., p. A89. http://access.bl.uk/ark:/81055/vdc_100137792376.0x00004c